EAS Congress: Lowering lipoprotein(a) for clinical benefit: How much?Low LDL cholesterol due to PCSK9 variants reduces mortality Real-world use of PCSK9 inhibitors First data from the Homozygous Familial Hypercholesterolaemia International Clinical Collaborators (HICC) Registry

Thank you for subscribing

Dear Colleague,

We are delighted that you have confirmed your consent and agreed to resubscribe to PCSK9 Forum to receive important information and updates from us.

Kind regards,

John Chapman and Henry Ginsberg

About PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is a not-for-profit organisation established by leading researchers in the fields of atherosclerosis, lipids and cardiovascular disease. The PCSK9 Education and Research Forum is focused on raising awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target. As part of its remit, PCSK9 Education and Research Forum offers healthcare professionals open access to electronic and multimedia platforms providing real-time reporting of significant developments and news; authoritative analysis and commentary; as well as an extensive library of accredited educational materials tailored to the differing needs of registrants.

Our Partnership and Outreach

Through its unique global network of researchers and clinicians, the PCSK9 Education and Research Forum connects academic institutions, research organisations and societies which share the Forum’s commitment to the reduction of CVD mortality and morbidity through improved management of atherosclerotic dyslipidaemia. The Forum builds on educational partnerships with such organisations through jointly sponsored symposia, as well as accredited research and educational programmes.

Educational Partners and Supporters

Thank you for subscribing

Find out more

About PCSK9 Education and Research Forum

Our Partnership and Outreach